Introduction
The aim of this audit was to establish current provision in termination of pregnancy (TOP) in National Health Service (NHS) Trusts in Wales, to extract examples of good practice and highlight areas requiring attention before preparing an all-Wales TOP integrated care pathway.
A recent briefing paper by the British Medical Association's Medical Ethics Committee made several suggestions to increase efficiency 1 supported by a Parliamentary Select Committee. 2 This included removal of medical criteria for first-trimester abortion, requirement for two doctors' signatures and, controversially, supporting suitably trained nurses/midwives in performing medical (MTOP) and surgical (STOP) termination of pregnancy.
In 2006, 90% of abortions in Wales were NHS-funded and of these 32% took place in the independent sector in England under NHS contract. 3 In Wales, 60% of abortions were performed at less than 10 weeks' gestation. In England and Wales, 30% of abortions were performed medically, this figure more than doubling in the last 5 years. 3 The average NHS cost of an abortion is £827 for STOP and £568 for MTOP. 4
Methods
Research governance approval was obtained from 13 NHS Trusts. A questionnaire in English and Welsh based on national guidelines 5 plus demographic abortion questions was sent to the lead NHS Trust nurse/midwife in Spring 
Information for women
Verbal information should be supported by written impartial, printed material. 5 Five Trusts included the written information (as requested) given during the initial consultation and on discharge. This varied in both content and presentation. All leaflets outlined risks of complications. 5
Pre-abortion management
Some unnecessary tests were performed such as blood cross-matching, whilst HIV and hepatitis B and C were screened in only some Trusts (Table 3 ). All but one Trust performed either a vaginal or abdominal scan in all cases. Two Trusts performed vaginal scans only.
Abortion procedures
Contrary to national guidelines, 5 three Trusts provided MTOP only and one Trust referred most TOPs out of Wales. The remaining six Trusts provided a choice of MTOP and STOP (Table 1) . No Trusts performed STOP under conscious sedation or local anaesthesia. One Trust is currently implementing a feasibility study regarding the possibility of outpatient MTOP.
Medication
Misoprostol can be administered by the nurse/midwife or the patient. 5 Six of eight responders stated misoprostol was always (n = 5) or often (n = 1) given by the nurse/midwife. In two Trusts it was often (n = 1) or always (n = 1) administered by the patient. All Trusts complied with the time interval between mifepristone and prostaglandin for MTOP. 5 One Trust administered gemeprost instead of misoprostol.
Abortion aftercare
Compliance varied for post-abortion tests and services (Table 4) . Immunoglobulin G was always administered if appropriate and the majority of Trusts administered prophylactic antibiotics and analgesia. 5 However, routine histological tests were performed by three Trusts, contraceptive supplies were issued sporadically and follow-up appointments and counselling were not offered by all Trusts.
Discussion

Organisation of services in Wales
Department of Health statistics show that in Wales 90% of abortions are provided through NHS (58%) or NHS agency (32%) and 10% are classified as non-NHS. 3 These figures are encouraging as they suggest improved access but recent concerns about illegal abortions in the UK should counter complacency regarding access. 8 TOP services differ markedly throughout Wales, with some Trusts contracting out services (Table 1) . Rurality and service provision in parts of Wales reduced accessibility and choice, possibly adding to stress for women at a vulnerable time. Table 1 shows a high proportion of MTOP but it should be noted that NHScontracted abortions (mainly STOP) were not included.
Conscientious objection allows doctors to refuse participation in abortion. 9 With more doctors choosing to conscientiously object, shortages of staff working in this area have been predicted. 10,11 Involving doctors in training should help to provide sufficient numbers of trained staff willing to work in the area and has been shown to improve attitudes. 12 The majority of Trusts performing MTOP provided an ostensibly nurse-led service with doctors writing prescriptions and attending any emergencies as advised by a recent Health Technology Assessment. 13 In a USA study results of experienced physician assistants performing STOP were comparable to physicians. 14 This possibility has been debated in the UK recently. 1, 15 The House of Commons Select Committee also advocates expansion of nurses'/midwives' role. 2
Referral times and assessment
Only one Trust did not comply with time from initial referral to TOP according to national guidelines. 5 This shows the effort made to streamline services, particularly when some are rural. This compares favourably with international studies where barriers were found regarding access. [16] [17] [18] 
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©FSRH sources. Information should be impartial and based on that provided by national bodies. 5 A UK randomised controlled trial (RCT) demonstrated that although there was no difference in TOP method chosen, women provided with the decision aid leaflet had higher knowledge and lower risk perception scores about both. 20 The authors recommend that an evidence-based decision aid leaflet be provided before initial consultation.
Pre-abortion tests
Some tests were unnecessarily performed. In a USA study of 7000 MTOP patients only four women required a blood transfusion; extrapolating these results to the UK would negate the need for regular cross-matching. 21 Some Trusts never performed HIV, hepatitis B and C tests, or cervical smears. A risk-benefit assessment exercise should be done in those Trusts. Although the majority of Trusts complied with guidelines on antibiotic prophylaxis and chlamydia screening 5 there remains room for improvement (Table 2) . Chlamydia screening needs to be undertaken sensitively as demonstrated by a systematic review of women's views. 22 Viewing TOP as part of integrated sexual health strategy will help Trusts assimilate TOP into women's sexual health. 23 
Abortion procedures
In six Trusts women were able to choose their method of abortion depending on gestation 5 (Table 1 and Figure 1) . A study by Ho demonstrated that two subsets of women (ie, those that had STOP and those that had MTOP) found TOP to be convenient. 24 A Danish study found that satisfaction with both methods was high, and was higher when women were given a choice of method. 25 It is likely that local expertise as well as cost 4 influences service provision in Wales to a greater extent than women's choice.
Conscious sedation is considered safer than a general anaesthetic. 26 Guidelines have been available for this procedure since 2002, but it requires a skilled sedationist and no Trusts in this study performed STOP using this or local anaesthetic. Effectiveness of local anaesthetic has been called into question 27 where high rates of posttraumatic stress disorder were found in STOP patients receiving local anaesthetic.
Half the Trusts were able to offer dedicated clinics for women at their assessment. 5 An English study on women's perceptions of TOP care found staff friendliness and being dealt with sensitively important 19 and a dedicated clinic might achieve this.
Information for women
Although the majority of Trusts had arrangements for women with special needs such as those changing their mind, or needing more support, no policies were included with the response. Only three Trusts had measures in place for illiterate women to be informed about TOP.
Only OPD, outpatients department; PRN, pro re nata ('as needed').
TOP service provision in Wales
RECOMMENDATION 28
Conventional suction termination should be avoided at gestations below 7 weeks. B Gestation (weeks from date of last menstrual period) 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 1 Medical abortion using a single oral dose of the anti-progesterone, mifepristone, followed by a single dose (vaginal or oral) of prostaglandin (also known as pharmacological or non-surgical abortion). 2 Medical abortion using a single oral dose of the anti-progesterone, mifepristone, followed by multiple doses (vaginal or oral) of prostaglandin (also known as pharmacological or nonsurgical abortion). 3 Surgical abortion by means of suction aspiration (using electric or manual suction) at gestations below 7 weeks. To increase confidence that the gestation sac has been removed, protocols include safeguards such as magnification of aspirate and follow-up serum ␤hCG estimation. 4 Conventional suction termination using electric or manual suction, under general or local anaesthetic. The uterus is emptied using a suction curette. Sharp curettage with metal instruments is not employed. 5 Surgical abortion at later gestations using a combination of suction (usually electric) curettage and specialised forceps.
Medical abortion using mifepristone and multiple doses of prostaglandin 2 Medical abortion using mifepristone and prostaglandin 
A recent pilot project in the South of England has shown that abortion can be safely performed outside hospital under controlled conditions. 28 Previously in the UK there has been reluctance by women to undertake selfadministration of medication 29 or consider MTOP at home. 30 Nevertheless, studies in the USA and Canada have shown that in the right circumstances home MTOP is effective [31] [32] [33] as well as increasing a sense of control in women. 34 A recommendation to exclude the second stage of early MTOP from the definition of 'carrying out an abortion' will allow further trials to take place. 2
Medication
Allowing women to self-administer vaginal misoprostol only occurred in two Trusts. Nevertheless recent research showed it to be 100% successful with attendant patient satisfaction. 29 Allowing patient participation would return some control to women and could increase their sense of involvement and responsibility for their health.
All Trusts complied with guidelines regarding the time interval between mifepristone and prostaglandin for MTOP. 1 A review 32 based on five RCTs claimed that the interval can be reduced from 48 to 24 hours without loss of efficacy, and further recommends that there is sufficient evidence to reduce this time period to 6-8 hours. However, results of an RCT comparing misoprostol either 6 hours later or 36-48 hours after mifepristone 35 showed less efficacy at 6 hours. On this basis, reducing the time interval between stages in MTOP could proceed with caution.
A study comparing both gemeprost and misoprostol in first-trimester abortions found them to be equally effective. 36 Mean cost per patient was US$1.48 (£0.98) for misoprostol and US$85.79 (£57.08) for gemeprost. 37 Based on this evidence, the sole Trust using gemeprost instead of misoprostol would need to justify its continued use. 5
Abortion aftercare
Rhesus typing and anti-D immunoglobulin G were performed as per national guidelines 5 although there is little evidence sensitisation could occur under 63 days' gestation. 38 Although routine histological testing of tissue is deemed unnecessary, in three Trusts where this took place TOPs were mainly undertaken for fetal abnormality.
Antibiotic prophylaxis was only provided sometimes by two Trusts despite it preventing both short-and longterm detrimental effects. 5 Compliance with analgesia was evident in the majority of Trusts where administration was based on patient need and pain assessment.
In never providing contraceptive supplies, two Trusts missed opportunities to check that women have adequate contraception immediately following TOP. 5, 38 In a USA study most participants were not using contraception at the time of conception. 39 Post-abortion counselling is recommended as being available for the minority of women who may require it 5 and as far as can be ascertained this is the case in Wales. In a recent phenomenological study an attempt was made to gain insights into a complex situation. 40 However, whether counselling positively influences long-term outcomes is by no means certain. 41 A major limitation of this study was the questionnaire design as the aim was to capture the maximum amount of data whilst keeping the questionnaire simple. Inevitably, the quest for the maximum amount of data overrode simplicity and some of the resultant data were analysed with difficulty. In hindsight, piloting the questionnaire using an English NHS Trust would have minimised these difficulties.
Conclusions
RCOG guidelines were first introduced in 2000 and have since been updated. 5 A further update is recommended via the National Institute for Health and Clinical Excellence. 2 The purpose of this study was to examine abortion services in Wales and their adherence to current RCOG guidelines in preparation for development of an integrated pathway of care.
Stricter adherence to guidelines by some Trusts would reap clinical benefits. Opportunity for doctors in training to be exposed to or contribute to TOP care and treatment in each NHS Trust in Wales together with dedicated TOP clinics is commended as evidence-based practice. 12, 19 As a result of this audit, development is currently underway of an all-Wales template for patient information and TOP choice with local adaptation by each Trust, as well as an all-Wales multidisciplinary pathway of care for TOP to encourage compliance with RCOG guidelines and streamline care.
It would be prudent of Trusts to rationalise preabortion testing according to RCOG guidelines to reduce inefficiency. In line with greater patient involvement, there is more scope for misoprostol to be administered by women undergoing abortion. There is opportunity to provide contraception immediately after TOP to reduce risk of a repeat procedure.
In some instances, compliance may have resource implications such as the need to provide a dedicated TOP clinic. However, the extra resources required could be offset against the cost of unnecessary tests and investigations that are performed in some instances.
